You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ZVRA Exercise Disclosure
Mcfarlane Neil F. · SEC Form 4 · Filed Oct 13, 2026
Exercise
Calculated transaction value
$0
Mcfarlane Neil F. President And CEO
ZVRA
Zevra Therapeutics
ZVRA
Transaction date
Oct 10, 2026
Public filing date
Oct 13, 2026
Filing lag
Filed 3 days later
ZVRA daily price context
Close on/before transaction
$11.39
Oct 9, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Unit on Common Stock
- Quantity / price
- 50,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001434647-26-000075
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$224.95K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Zevra Therapeutics, Inc. ZVRA | Sale | Oct 12, 2026 | $224.95K |
| Zevra Therapeutics, Inc. ZVRA | Exercise | Oct 10, 2026 | Not reported |
| Zevra Therapeutics, Inc. ZVRA Current | Exercise | Oct 10, 2026 | $0 |